Sudie Back to Analgesics, Opioid
This is a "connection" page, showing publications Sudie Back has written about Analgesics, Opioid.
Connection Strength
2.637
-
Motives for prescription opioid use: The role of alexithymia and distress tolerance. Am J Addict. 2022 01; 31(1):55-60.
Score: 0.517
-
Laboratory-induced stress and craving predict opioid use during follow-up among individuals with prescription opioid use disorder. Drug Alcohol Depend. 2021 08 01; 225:108755.
Score: 0.505
-
Pain management perceptions among prescription opioid dependent individuals. Drug Alcohol Depend. 2014 Sep 01; 142:354-8.
Score: 0.313
-
Characteristics and correlates of men and women with prescription opioid dependence. Addict Behav. 2011 Aug; 36(8):829-34.
Score: 0.250
-
Gender and prescription opioids: findings from the National Survey on Drug Use and Health. Addict Behav. 2010 Nov; 35(11):1001-7.
Score: 0.237
-
Prescription opioid aberrant behaviors: a pilot study of sex differences. Clin J Pain. 2009 Jul-Aug; 25(6):477-84.
Score: 0.221
-
Sleep moderates the relationship between stress and craving in individuals with opioid use disorder. Exp Clin Psychopharmacol. 2021 Aug; 29(4):418-426.
Score: 0.117
-
Sensitized brain response to acute pain in patients using prescription opiates for chronic pain: A pilot study. Drug Alcohol Depend. 2019 07 01; 200:6-13.
Score: 0.109
-
Patient Perspectives Associated with Intended Duration of Buprenorphine Maintenance Therapy. J Subst Abuse Treat. 2015 Sep; 56:48-53.
Score: 0.083
-
Discontinuation of buprenorphine maintenance therapy: perspectives and outcomes. J Subst Abuse Treat. 2015 May; 52:48-57.
Score: 0.081
-
Pilot of a brief, web-based educational intervention targeting safe storage and disposal of prescription opioids. Addict Behav. 2013 Jun; 38(6):2230-5.
Score: 0.071
-
Comparative profiles of men and women with opioid dependence: results from a national multisite effectiveness trial. Am J Drug Alcohol Abuse. 2011 Sep; 37(5):313-23.
Score: 0.064
-
Self-report and urine drug screen concordance among women with co-occurring PTSD and substance use disorders participating in a clinical trial: Impact of drug type and participant characteristics. Drug Alcohol Depend. 2023 03 01; 244:109769.
Score: 0.035
-
Transcutaneous cervical vagus nerve stimulation reduces behavioral and physiological manifestations of withdrawal in patients with opioid use disorder: A double-blind, randomized, sham-controlled pilot study. Brain Stimul. 2022 Sep-Oct; 15(5):1206-1214.
Score: 0.034